Brainsway (BRSYF) EPS (Weighted Average and Diluted) (2025 - 2026)
Brainsway posted quarterly EPS (Weighted Average and Diluted) of $38183.3 for Q1 2026, down 31.01% year-on-year from $55350.0 in Q1 2025, and down 31.01% on a QoQ basis from $55350.0 in Q1 2025.
Brainsway (BRSYF) has 2 years of EPS (Weighted Average and Diluted) data on file, last reported at $38183.3 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Weighted Average and Diluted) fell 31.01% year-over-year to $38183.3; the trailing twelve-month figure through Mar 2026 stood at $38183.3 (down 31.01% YoY), and the FY2025 full-year result was $0.18, up 260.0% from the prior year.
- EPS (Weighted Average and Diluted) for Q1 2026 stood at $38183.3, down from $55350.0 in the prior quarter.
- Across five years, EPS (Weighted Average and Diluted) topped out at $55350.0 in Q1 2025 and bottomed at $38183.3 in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.61 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 1.93 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.89 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.90 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.66 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.51 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.85 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 2.24 |
| 10 | Brainsway | - | - | 11.68 Mn | 38,183.33 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38,183.33 |
| Mar 31, 2025 | 55,350.00 |